Skip to main content

Second Actos Bladder Cancer Lawsuit Goes to Trial in Baltimore

By September 16, 2013April 4th, 2022Actos, Pharmaceutical litigation, Uncategorized

actos_bladder_cancer_lawsuits_settlements_diabetes_litigation_fda_warningThe second Actos bladder cancer lawsuit is currently on trial in the Circuirt Court for the City of Baltimore.

The plaintiffs in the case, the family of Diep An, a former Actos user who died from bladder cancer in January 2012, filed their Actos lawsuit contending that the diabetes drug was the cause of Diep An’s bladder cancer and death.

In opening arguments delivered in early September, the plaintiffs’ legal counsel argued that Takeda Pharmaceuticals, the Japanese company responsible for the development and marketing of Actos, did not make patients aware about the risks involved with using Actos, specifically about the bladder cancer risk. According to the plaintiffs’ lawyer, Takeda Pharmaceuticals instead focused on Actos sales.

As detailed in a Bloomberg report, the Diep An Actos bladder cancer lawsuit is the second case in over 3,000 to go to trial. Of the 3,000 Actos lawsuits in the U.S., approximately 1,200 have been consolidated into a federal court in Louisiana, with the  first case set to go to trial in January 2014. Carey Danis & Lowe Actos lawyers are interested to see, come January, how the federal trial affects lawsuits across the nation.

Still on the market in the United States, but banned in both France and Germany following a French epidemiological study, Actos is a drug used to treat diabetes. Due to increased reports of patients developing bladder cancer while using Actos, the U.S. Food and Drug Administration (FDA), reviewed a ten year Actos study, whose results are due out next year.

In its review of the partial data from the collaborative study conducted by Takeda Pharmaceuticals and Kaiser Permanente Northern California, the FDA found that in patients taking high dosages of Actos for longer durations, there exists a higher risk of developing bladder cancer.

Plaintiffs have filed Actos bladder cancer lawsuits alleging that Takeda Pharmaceuticals knew about the bladder cancer risk, yet made the decision to dismiss it as the drug was released onto the market.

If you or someone you love has been harmed by Actos, the experienced lawyers and medical experts at Carey Danis & Lowe are here to help. Receive a free legal consultation about your Actos case, and get medical advice from one of our nurses.

Contact Carey Danis & Lowe today by calling 800.721.2519, or by submitting a personal injury claim form.